BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2865857)

  • 1. [Effect of celiprolol compared to propranolol on thyroid metabolism].
    Langsteger W; Lind P; Eber O
    Wien Med Wochenschr; 1985 Sep; 135(18):451-7. PubMed ID: 2865857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Haemodynamic characterization of a new beta-receptor blocker celiprolol (st1396) at rest and during ergometer exercise compared with propranolol (inderal) (author's transl)].
    Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
    Wien Klin Wochenschr; 1978 May; 90(10):350-4. PubMed ID: 26139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
    Klieber M; Resch F
    Wien Klin Wochenschr; 1986 Feb; 98(3):70-3. PubMed ID: 2938341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
    Matthys H; Doshan HD; Rühle KH; Applin WJ; Braig H; Pohl M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S40-2. PubMed ID: 2427851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
    Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
    Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antihypertensive effects of celiprolol and enalapril.
    Ghiringhelli S; Cozzi E; Tsialtas D
    J Int Med Res; 1988; 16 Suppl 1():73A-79A. PubMed ID: 2906019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The results of a celiprolol drug surveillance study in Spain. The Celiprolol Multicenter Group].
    An Med Interna; 1989 Dec; 6(12):619-23. PubMed ID: 2535249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP; Lamon KD; Hagen NS
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma levels and the antihypertensive effect of the preparation celiprolol].
    Vlakhov N; Belovezhdov N; Terziivanov D; Koĭchev A; Stefanov G
    Vutr Boles; 1986; 25(6):62-6. PubMed ID: 2951925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta blockade with celiprolol in tardive dyskinesia patients treated with neuroleptics].
    Hebenstreit GF; Hoffmann H; Hoffmann W; Pittner H
    Wien Klin Wochenschr; 1986 Jun; 98(12):388-92. PubMed ID: 2874663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies of celiprolol in the treatment of arterial hypertension].
    Belovezhdov N; Nachev Ch; Angelova I; Gergova V; Stefanov G
    Vutr Boles; 1985; 24(5):74-7. PubMed ID: 2868573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of celiprolol and propranolol in the treatment of hypertension in one hundred and seventy-nine subjects.
    Leary P; Mayol R; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():70-2. PubMed ID: 2864068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.